Only WHO-Compliant Formulas Can Use ORS Tag: FSSAI Cracks Down on Misleading Beverage Labels Susmita Roy17 Oct 2025 9:40 PM ISTNew Delhi: In a decision to protect consumers from misleading claims and prevent companies from marketing sugary or flavored drinks as medical...
Indian Pharma Defies GST Jolt, Posts 7.3% Growth in September: Report Susmita Roy16 Oct 2025 8:18 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has recorded a 7.3% value growth in September 2025, driven primarily by new product introductions...
Health Ministry Draft Rules: Only Engineering or Pharmacy Graduates Eligible to Become Medical Device Inspectors, Analysts Susmita Roy15 Oct 2025 6:22 PM ISTNew Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare (Department of Health and Family Welfare) has issued a...
Torrent-JB Chemicals Rs 25,689 Crore Merger Under CCI Lens Over Monopoly Concerns Susmita Roy14 Oct 2025 5:57 PM ISTNew Delhi: The Competition Commission of India (CCI) has expressed serious concerns over the proposed merger between Torrent Pharmaceuticals and JB...
Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision's NEXADOM Drug Susmita Roy13 Oct 2025 9:34 PM ISTNew Delhi: The Delhi High Court has granted an ex-parte ad-interim injunction in favour of Sun Pharmaceutical Medicare, a subsidiary of Sun...
Kerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong Packaging Susmita Roy12 Oct 2025 2:00 PM ISTNew Delhi: In a serious lapse that could have endangered patient safety, the Regional Cancer Centre (RCC) in Thiruvananthapuram has barred Globela...
Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy Susmita Roy11 Oct 2025 9:41 PM ISTNew Delhi: The Delhi High Court has dismissed an appeal filed by Swiss drug major F. Hoffmann-La Roche AG and its Indian arm, challenging the order of...
Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales Farhat Nasim10 Oct 2025 3:46 PM ISTNew Delhi: In a remarkable rise, Eli Lilly's Mounjaro (tirzepatide) has become India's second-highest selling drug by value within just six months of...
Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects Susmita Roy9 Oct 2025 11:02 PM ISTNew Delhi: Noting the possible risk of expected adverse effects in healthy subjects, the Subject Expert Committee (SEC), functioning under the Central...
Exemed Pharma's Empagliflozin-Vildagliptin Combo Rejected by CDSCO Panel Over Questionable Clinical Use Susmita Roy8 Oct 2025 8:04 PM ISTNew Delhi: In a setback to Exemed Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO)...
Wockhardt Misses NPPA Clearance for Nafithromycin, Faces Questions on Patent Validity Susmita Roy7 Oct 2025 9:56 PM ISTNew Delhi: In a temporary setback to Wockhardt, the National Pharmaceutical Pricing Authority (NPPA) has sought further clarifications from the...
Price Cap Exemption Pending: NPPA Refers Biodeal Pharma's Midazolam Nasal Spray to CDSCO, SNCM for Review Susmita Roy6 Oct 2025 8:54 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), while considering an application submitted by Biodeal Pharmaceuticals Limited seeking...
